ICD-10-CM Billable Code

C51.1

Malignant neoplasm of labium minus

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the labium minus refers to a cancerous growth located on the inner part of the vulva, known as the labium minus. This type of cancer is a form of vulvar cancer, which primarily affects women and involves the tissues of the vulva. Recognizing the signs and understanding the factors involved can help in early detection and treatment.

Causes & Symptoms

Clinical Causes: Persistent human papillomavirus (HPV) infection, especially high-risk strains Chronic vulvar skin conditions such as lichen sclerosus Smoking and related exposure to carcinogens Older age, with higher incidence in postmenopausal women History of vulvar intraepithelial neoplasia (VIN) or other precancerous changes

Key Symptoms: Persistent or unusual vulvar itching Presence of a growth, lump, or ulcer on the labium minus Discomfort or pain, particularly during urination, intercourse, or walking Changes in skin color or thickening of the vulvar area Bleeding or unusual discharge from the vulva Sensation of a mass or swelling in the vulvar region

Diagnostic & Treatment

Diagnosis Path: Detecting malignant neoplasm of the labium minus involves a comprehensive clinical examination. A healthcare provider may perform a vulvar biopsy, taking a small tissue sample from the suspicious area for laboratory analysis. Additional diagnostic procedures such as colposcopy, imaging studies, or sentinel lymph node biopsy may be used to evaluate the extent of spread and plan appropriate treatment.

Treatment Protocols: Treatment options depend on the stage and extent of the cancer and may include surgical removal of the tumor, which could involve local excision, vulvectomy, or more extensive procedures if necessary. Radiation therapy, chemotherapy, or targeted therapies might be recommended, either alone or combined, especially for advanced cases. Post-treatment follow-up is essential to monitor for recurrence and manage any side effects.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C51.1 a billable ICD-10 code?
Yes, C51.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C51.1?
Clinical documentation must specify the nature of Malignant neoplasm of labium minus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

neoplasm labium malignant minus